Skip to content

The Trial of Ewata Balloon Guiding in the Application of Thrombectomy

The Trial of Ewata Balloon Guiding in the Application of Thrombectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04315844
Enrollment
122
Registered
2020-03-20
Start date
2017-07-25
Completion date
2020-09-30
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Keywords

AIS balloon guiding

Brief summary

To evaluate the efficacy and security of Ewata combined with a stent device in the treatment of acute ischemic stroke within 8 hours To prove whether the clinical efficacy and safety of Ewata r is not inferior to other guidings.

Detailed description

This clinical trial uses multicenter, single-arm, prospective trial design,people who met the enrollment requirements were performed with Ewata balloon guiding and stent type thrombectomy device.The clinical results were compared with those of other historical guiding catheter products combined with the stent type thrombectomy device to to evaluate the clinical efficacy and safety of Ewata balloon guide catheter in combination with a stent for thrombectomy.

Interventions

DEVICEEwata balloon guiding

The balloon guide catheter is coaxial cavity and reinforced braided catheter with varying stiffness echelon.The distal end is marked by an impermeable ray, the proximal end has a bifurcated ruhr interface, and the end is embedded with a compliance balloon.The product label indicates the size of the balloon guide catheter and the maximum volume of the balloon.

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Acute ischemic stroke 2. within 8 hours 3. Patients aged 18-80 years (including critical point) 4. NIHSS score 4-30 (including critical points) 5. Pre-onset mRS score \<2 6. Large vessel lesions were detected by head CT, CTA, MRI, MRA, or DSA 7. The patient or his legal guardian voluntarily signs and dates a written informed 8.consent approved by the ethics committee (IBC).

Exclusion criteria

1. Head CT

Design outcomes

Primary

MeasureTime frameDescription
technical success rate of ewataintraoperativeWhen the balloon guiding catheter arrives at the desired location, the thrombectomy instrument can enter the balloon guiding catheter smoothly, which can be opened successfully when needed to form a local blockage of blood flow. After the thrombectomy, the thrombectomy instrument can be withdrawn back into the guide catheter, which is considered as a success.Ewata balloon guide catheter should be used at least once during thrombectomy

Secondary

MeasureTime frameDescription
Rate of intraoperative adverse eventsintraoperativeincluding vascular perforation , incision,vasospasm caused by balloon guiding,balloon guide catheter rupture and other instrument-related accidents
The time from the successful puncture to the expected location of ewataintraoperativetime data
The time from successful puncture to recanalizationintraoperativetime data,TICI≥2b
Rate of symptomatic intracranial hemorrhage within 24 hours24 hoursCT/NIHSS
Rate of Vascular recanalizationpostoperativeTICI≥2b
90-day mortality90-dayThe number of all deaths reported will be recorded and adjudicated
Good prognosis rate at 90 days90 days(mRS≤2)
The thrombus escapes from the target vessel to other vessels to form new embolismintraoperativeThe form of New thrombosis Judged by DSA or MRA
24-hour mortality24-hourThe number of all deaths reported will be recorded and adjudicated

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026